2026-10-19——
PacBio and Verily Health announce multi-year collaboration linking HiFi sequencing to Verily Pre platform
A short entry: a summary of the public record, checked against its sources, not yet read and analysed by Gianluca. How the register works
On 19 October 2026, PacBio and Verily Health announced a multi-year strategic collaboration to integrate PacBio HiFi sequencing with Verily Health's governed data and AI platform, Verily Pre, combining long-read genomic data with real-world clinical data at population scale to produce AI-ready clinico-genomic datasets.
What happened
- Announced 19 October 2026 from Menlo Park, California and Dallas.
- The collaboration is multi-year.
- PacBio HiFi whole-genome sequencing workflows already run end-to-end within the Verily Pre environment.
- Verily Health will configure Pre Workbench as the secure governed research environment for aggregation, analysis, and curation of HiFi genomic datasets.
- The parties plan to use the Verily Pre trusted agentic environment (TAE) to run model training and inference.
- The release states Workbench serves more than 20,000 researchers and has supported more than 700 publications, and names neurology, oncology, and rare disease as target areas.
Who is involved
PacBioListed · NASDAQ: PACB
PacBio is a developer of high-quality, highly accurate sequencing solutions.
Verily Health
Sources
- investor.pacificbiosciences.com — primary
- contractpharma.com — corroborating
- en.wikipedia.org — party background
- sec.gov — party background
- fiercehealthcare.com — party background
- intuitionlabs.ai — party background
Announced 2026-10-19